Epidemiology

PD Statistics

  • Parkinson’s Disease (PD) is a chronic, neurodegenerative disorder second only to Alzheimer’s disease in prevalence. PD affects approximately 1% of the population over age 60.
  • An estimated 1 million people are living with PD in the U.S — more than the combined number of people with diagnosed multiple sclerosis, muscular dystrophy, and Lou Gehrig’s disease.
  • Cases are estimated to increase to 1.2 million by 2030.
  • Roughly 60,000 Americans receive PD diagnoses annually.
  • The incidence of PD increases with age; only 4% of cases are diagnosed before age 50.
  • Men are 1.5 times more likely than women to have PD.
  • Risk of developing PD appears to be increased by a combination of genetic and environmental factors.
  • Direct and indirect cost of PD (treatment, Social Security payments, lost income, etc.), is estimated at $52 billion per year in the U.S.
  • Medication costs average $2,500 annually; therapeutic surgery can cost up to $100,000 per person.

References

  • Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311:1670-1683.
  • Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 2018;4:21.
  • Parkinson’s Foundation. Statistics. Available at: https://www.parkinson.org/Understanding-Parkinsons/Statistics

Parkinsons

Copyright © 2019 | Thrive Parkinsons | All Rights Reserved | Website by Divigner

Patient Toolkit

The THRIVE Patient Toolkit is a resource center for patients who received diagnosis of or who are interested in learning about Parkinson’s disease. Choose from the options below to learn more.

Clinical Toolkit

The THRIVE Clinical Toolkit is an online tool that aims to provide clinicians up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for Parkinson’s disease. Click on one of the options below to learn more about PD.

This activity is supported by an independent medical education grant from AbbVie.

Copyright © 2019 | Diabetic Retinopathy | All Rights Reserved | Website by Divigner